Biomarkers To Aid Clinical Trials For Neurodegenerative Disease

Grant number: 1132604 | Funding period: 2018 - 2022

Active

Abstract

Alzheimer’s disease and Parkinson’s disease continue to affect more Australians every year, due to an ageing population and the lack of effective drugs currently available. Whilst these diseases present with different symptoms, we’ve discovered that they share a common underlying feature; the inability to clear certain metals and proteins from the brain. Our program aims to explore these clearance pathways in the brain and identify new targets to help us better diagnose and treat these diseases.